Maureen Sideris
patientFemale0.0Global Dominance: 0.00%
Maureen Sideris, a cancer survivor, gained attention after sharing her remarkable experience with immunotherapy as a treatment for gastroesophageal junction cancer. Diagnosed in 2022, she participated in a groundbreaking trial at Memorial Sloan Kettering, where she achieved complete remission without the need for traditional treatments like surgery, chemotherapy, or radiation, leading her to describe her outcome as akin to winning the lottery.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Maureen Sideris is a 71-year-old patient who has experienced complete remission of her gastroesophageal cancer.
Un anticuerpo humanizado de ratón hace desaparecer el cáncer de 84 personas con una mutación genética | Salud y bienestarEl País·
Spain· 2025-05-09
Spain· 2025-05-09
Maureen Sideris, who was diagnosed with gastroesophageal junction cancer in 2022, subsequently became a participant in the trial.
Medication alternative for cancer patients uses immunotherapy to avoid surgery, chemoFox News·
United States· 2025-04-29
United States· 2025-04-29
